0000899243-18-010892.txt : 20180427 0000899243-18-010892.hdr.sgml : 20180427 20180427170920 ACCESSION NUMBER: 0000899243-18-010892 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180425 FILED AS OF DATE: 20180427 DATE AS OF CHANGE: 20180427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Perlman Ezra CENTRAL INDEX KEY: 0001344015 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36778 FILM NUMBER: 18785414 MAIL ADDRESS: STREET 1: C/O FRANCISCO PARTNERS STREET 2: 2882 SAND HILL ROAD, SUITE 280 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONNECTURE INC CENTRAL INDEX KEY: 0001211759 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18500 W. CORPORATE DRIVE STREET 2: SUITE 250 CITY: BROOKFIELD STATE: WI ZIP: 53045 BUSINESS PHONE: 262-432-8282 MAIL ADDRESS: STREET 1: 18500 W. CORPORATE DRIVE STREET 2: SUITE 250 CITY: BROOKFIELD STATE: WI ZIP: 53045 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-04-25 1 0001211759 CONNECTURE INC CNXR 0001344015 Perlman Ezra C/O FRANCISCO PARTNERS MANAGEMENT, L.P. ONE LETTERMAN DRIVE, BUILDING C -STE 410 SAN FRANCISCO CA 94129 1 0 0 0 Common Stock 2018-04-25 4 J 0 3624022 0.00 D 0 I See Footnotes Series A Convertible Preferred Stock 2018-04-25 4 J 0 50000 0.00 D Common Stock 14629115 0 I See Footnotes Series B Convertible Preferred Stock 2018-04-25 4 J 0 16500 0.00 D Common Stock 10199839 0 I See Footnotes Consists of 2,414,050 shares of common stock, par value $0.001 per share ("Common Stock") of Connecture, Inc. (the "Issuer") directly held by Francisco Partners IV, L.P. ("FP IV") and 1,209,972 shares of Common Stock directly held by Francisco Partners IV-A, L.P. ("FP IV-A"). On April 25, 2018, FP Healthcare Merger Sub Corporation ("Merger Sub") and FP Healthcare Holdings, Inc. ("Parent") completed its merger (the "Merger") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of January 4, 2018, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, FP IV and FP IV-A (together, the "FP Investors") contributed all of the shares of Common Stock and Preferred Stock held by the FP Investors (the "Rollover Shares") to the Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares. The general partner of both FP IV and FP IV-A is Francisco Partners GP IV, L.P. ("FP GP"). The general partner of FP GP is Francisco Partners GP IV Management Limited ("FP GP Management" and collectively with FP IV, FP IV-A and FP GP, "Francisco Partners"). The Directors of FP GP Management are Mr. Dipanjan Deb and Mr. Tom Ludwig and the Investment Committee of FP GP Management consists of Mr. Deb, Mr. David Golob, Mr. Ezra Perlman, and Mr. Keith Geeslin. Mr. Perlman, an officer of an affiliate of Francisco Partners Management, L.P. ("Francisco Partners"), is a member of the board of directors of the Issuer. FP IV, FP IV-A, FP GP and FP GP Management are affiliates of Francisco Partners and have each filed a separate Form 4 reporting the acquisition of securities of the Issuer that each may be deemed to beneficially own. Mr. Perlman disclaims beneficial ownership of any securities of the Issuer that may be deemed to be beneficially owned by affiliates of Francisco Partners, including FP IV, FP IV-A, FP GP and FP GP Management, except to the extent of his pecuniary interest therein. The Series A Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $4.50 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series A Convertible Preferred Stock was equal to approximately 292.58 shares. The Series A Preferred Stock was convertible at any time and had no expiration date. Consists of 33,306 shares of Series A Preferred Stock directly held by FP IV and 16,694 shares of Series A Preferred Stock directly held by FP IV-A. The Series B Convertible Preferred Stock was convertible into Common Stock at a rate equal to (i) the sum of (a) the original purchase price ($1,000 per share) plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Common Stock at such time, which initially was $1.91 per share, subject to customary anti-dilution adjustments. As of April 25, 2018, the number of shares of Common Stock deliverable upon conversion of each share of Series B Convertible Preferred Stock was equal to approximately 618.17 shares. The Series B Preferred Stock was convertible at any time and had no expiration date. Consists of 10,991 shares of Series B Preferred Stock directly held by FP IV and 5,509 shares of Series B Preferred Stock directly held by FP IV-A. By: /s/ EZRA PERLMAN, Name: EZRA PERLMAN 2018-04-27